A large-scale study published in the Journal of Hypertension Jan. 20 suggests the calcium channel blocker amlodipine can lower hypertensive patients’ BP while simultaneously minimizing their long-term risk of developing gout.

The Mediterranean diet has been eclipsed as the U.S. News & World Report’s best-ranked heart-healthy diet for the first time in a decade, nudged out of the top spot by the popular Ornish diet.

A two-year collaboration between the North Carolina chapter of the American College of Cardiology and North Carolina Association of Free and Charitable Clinics was successful in providing thousands of underserved heart patients with free lipid-lowering therapy and clopidogrel.

More than 15% of adults in all U.S. states and territories were physically inactive between 2015 and 2018, according to recent data from the CDC, with estimates ranging from 17.3% to 47.7% between regions.

Black patients at a heightened risk for heart disease cut their CV mortality risk by 11% in a study that explored the cardiac benefits of the Transcendental Meditation technique.

The FDA has approved Novo Nordisk’s Ozempic—once-weekly semaglutide—for an expanded indication of CV risk reduction in people with type 2 diabetes and established heart disease.

Women’s blood vessels age at a faster rate than men’s, researchers from the Smidt Heart Institute at Cedars-Sinai reported this month—a finding that could explain some of the considerable sex gaps in CVD in men and women.

One Minneapolis cardiologist is concerned that people following the trendy Keto diet aren’t worrying enough about their fat intake.